Harness Technology Innovation Across Capsid Engineering & Delivery Routes to the CNS to Improve Biodistribution and Translate Gene Therapies for Neurological Diseases into and Through the Clinic

6th Annual Gene Therapy for CNS Summit

Maximize Gene Therapy’s Therapeutic Potential in Neurology

The 6th Gene Therapy for CNS Summit is returning to Boston with a refreshed agenda to match exactly with the priorities of the gene therapy field in 2024. With more companies than ever submitting INDs for neurological diseases, preparing for first-in-human trials, and novel capsids proving their worth in positive data readouts showing greater transduction, there’s a clear shift as the innovative promise becomes a reality.

Bringing in-depth content on how novel AAVs are performing in preclinical models, maximizing biodistribution through a variety of administration routes, and applying the significant progress and successes from the first approvals in rare, genetic diseases to more complex, larger patient populations like Alzheimer’s and Parkinson’s.

Join neurology experts who are leveraging gene therapy as the premier modality to tackle neurological disease, across translational, preclinical, R&D, and clinical teams who are dedicating their day-to-day to advance their neurological assets into and through the clinic.

World-Class Speaker Faculty Includes:

Previously Attending Companies Include:

Photo of previously attending companies - Gene Therapy for CNS

Testimonials:

Our Partners

Other Events in the Series